Status:
COMPLETED
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
Lead Sponsor:
Cairo University
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
study \& verify the hypothesis of the involvement of TSLP in the pathogenesis of vitiligo in comparison to their levels in the healthy control persons.
Eligibility Criteria
Inclusion
- • Patients with generalized non-segmental vitiligo.
- Both sexes.
- Age \< 18 years old age.
- New cases or cases not receiving any medication for at least 3 months ago.
Exclusion
- • Age: Patients \< 18 years.
- Segmental or universal vitiligo.
- Pregnant and lactating females. Autoimmune diseases
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03367273
Start Date
January 1 2017
End Date
July 1 2017
Last Update
December 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.